Literature DB >> 14965705

Occult primary breast carcinoma presenting as axillary lymphadenopathy.

Catherine Shannon1, Geraldine Walsh, Francisco Sapunar, Roger A'Hern, Ian Smith.   

Abstract

BACKGROUND: The objective of this study was to review the need for radiotherapy or not in patients with occult primary breast cancer presenting with axillary metastases treated with breast conservation usually with no surgery to the breast.
METHODS: From 1975 to 2001, 58 patients were treated with axillary lymphadenopathy from a cryptic primary breast carcinoma. After clinical and radiological assessment, 29 patients retained a diagnosis of occult primary breast carcinoma. Clinical and pathological data were collected retrospectively on the 29 patients and survival was calculated from the date of initial diagnosis using the Kaplan-Meier method. The median follow-up was 44 months.
RESULTS: Median age at diagnosis was 57 years (range 28-81 years). Sixteen patients had radiotherapy to the ipsilateral breast. Eleven patients received no local therapy to the ipsilateral breast and two patients had quadrantectomies which were negative for malignancy. Locoregional relapse occurred in 12.5% of patients who had received radiotherapy and 69% of those who had not received any radiotherapy (P=0.02). Fifty-seven per cent of patients having a local relapse were salvaged with further surgery. The eventual breast conservation rate was 93%. Patients who received radiotherapy to the breast had significantly improved relapse-free survival (HR=0.31; P=0.04) and local relapse-free survival (HR=0.09; P=0.004). There were no significant differences in overall survival between those patients who had breast irradiation and those who did not (HR 0.91; 95% CI 0.18-4.5).
CONCLUSION: Occult primary carcinoma with axillary metastases can be treated successfully with breast preservation but radiotherapy to the breast is necessary to minimize the risk of locoregional recurrence.

Entities:  

Year:  2002        PMID: 14965705     DOI: 10.1054/brst.2002.0455

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  9 in total

Review 1.  [Radiotherapeutic concepts in cancer of unknown primary site].

Authors:  D Krug; J Debus; F Sterzing
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

2.  Population-based analysis of occult primary breast cancer with axillary lymph node metastasis.

Authors:  Gary V Walker; Grace L Smith; George H Perkins; Julia L Oh; Wendy Woodward; Tse-Kuan Yu; Kelly K Hunt; Karen Hoffman; Eric A Strom; Thomas A Buchholz
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

3.  Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER Database.

Authors:  Byoung Hyuck Kim; Jeanny Kwon; Kyubo Kim
Journal:  Cancer Res Treat       Date:  2017-06-01       Impact factor: 4.679

Review 4.  Occult breast cancer: Where are we at?

Authors:  Adam Ofri; Katrina Moore
Journal:  Breast       Date:  2020-10-27       Impact factor: 4.380

5.  Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study.

Authors:  Zijun Zhao; Ting Zhang; Yu Yao; Xin Lu
Journal:  BMC Surg       Date:  2022-04-17       Impact factor: 2.030

6.  Breast cancer presenting as unilateral arm edema.

Authors:  Shaheen Zakaria; Ruth Johnson; Barbara A Pockaj; Amy C Degnim
Journal:  J Gen Intern Med       Date:  2007-05       Impact factor: 5.128

7.  Comparable Survival between Additional Radiotherapy and Local Surgery in Occult Breast Cancer after Axillary Lymph Node Dissection: A Population-based Analysis.

Authors:  San-Gang Wu; Wen-Wen Zhang; Jia-Yuan Sun; Feng-Yan Li; Huan-Xin Lin; Yong-Xiong Chen; Zhen-Yu He
Journal:  J Cancer       Date:  2017-10-17       Impact factor: 4.207

8.  Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study.

Authors:  Li-Ping Ge; Xi-Yu Liu; Yi Xiao; Zong-Chao Gou; Shen Zhao; Yi-Zhou Jiang; Gen-Hong Di
Journal:  Cancer Manag Res       Date:  2018-10-09       Impact factor: 3.989

9.  A retrospective study of optimal surgical management for occult breast carcinoma: Mastectomy or quadrantectomy?

Authors:  Yajing Huang; Hao Wu; Zhiyong Luo
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.